Funding Opportunities
Grants
SVRI Data to Evidence Grant 2027: Knowledge for Action to End Violence Against Women and Child Sexual Violence
The SVRI’s Data to Evidence Grant 2027 supports researchers based in low- and middle-income countries to analyse data that has already been collected, generating new evidence to answer questions the field has not yet resolved. The Data to Evidence Grant will fund LMIC-based researchers to conduct secondary data analyses, generating new evidence on questions the field has not yet answered and putting it in the hands of researchers, policymakers and practitioners. SVRI will also provide technical assistance and mentorship, strengthening the skills of researchers in secondary data analysis that then can apply to other datasets in the future. Applicants may propose analysis of any dataset relevant to VAW and CSV provided the dataset has been ethically sourced and the applicant can demonstrate they have the necessary approval to use it. A number of existing datasets relevant to the field are listed on SVRI’s datasets page. Applicants are encouraged to consult this page, though use of a dataset not listed there is equally welcome, provided it meets the ethical sourcing and approval requirements set out below.
Due date: 17 September 2026, 11:59 pm (South African time)
For more information click: https://www.svri.org/svri-research-grant/?#apply-for-svri-research-grant
New Anthropic – Funding better evaluations of AI’s impact on wellbeing
We’re launching a $5 million grant program to fund independent research into how AI impacts users’ wellbeing. The program will provide direct funding, access to our models, and technical support to grantees building open-source evaluations that help the AI industry measure how our models affect those who use them. Example research topics include (but are not limited to):
- Detecting harmful dependence or emotional attachment: (a) benchmarks that score conversations for linguistic and behavioral signals that a user’s wellbeing or overall functioning is being negatively impacted, or (b) work that lays the foundation for benchmarking by identifying and validating potential signs of user well-being harms against real-world evidence of impact to the user.
- Measuring engagement maximizing behavior in model responses: measurements to determine whether a model’s responses optimize for continued interaction rather than what’s best for the user.
- Assessing whether and how models reinforce distorted thinking or negative self-talk: evaluations that score a model’s responses to a user who expresses such patterns and determine whether the model’s replies reinforce or counteract them.
Due date for Expression of interest: 21 September 2026
For more information click: https://www.anthropic.com/news/wellbeing-research-grants
Wellcome Discovery Awards
This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.
Due date: 22 September 2026, 15:00 BST
For more information click: https://wellcome.org/research-funding/schemes/wellcome-discovery-awards
Therapeutic Catalyst
This scheme provides opportunities to accelerate the translation of laboratory discoveries into novel cancer therapeutics. Projects are run collaboratively by an academic laboratory and Cancer Research Horizons’ team of over 180 experienced drug discovery scientists. Before making an application, we strongly recommend that you discuss the project with a member of our Therapeutic Translation team within Cancer Research Horizons. They can support you with advice on the available schemes and the application process. You must first submit an expression of interest making it clear which award you are applying for (i.e. Target or Early Therapy). An internal cross-functional committee will triage and review the therapeutic potential of the project and feasibility for eligibility and strategic fit. If successful, you will be invited to submit a full project proposal.
Due date: 25 September 2026
New Cancer Research UK: Therapeutic Catalyst
Our Therapeutic Catalyst awards are focused on new ways to treat adult cancers using antibody-based therapeutics or small molecule approaches spanning the whole range of formats within these modalities. Before making an application, we strongly recommend that you discuss the project with a member of our Therapeutic Translation team within Cancer Research Horizons. They can support you with advice on the available schemes and the application process. Therapeutic Catalyst categories; Target Award – This award can provide funding of up to £250k for 12 – 18 months. It is focused on one of two areas:
- cancer target identification – using novel model systems and/or analytical methods
- validation of novel cancer targets – including insights into cancer target dependency and clinical positioning
Such projects may include collaborative approaches with our Functional Genomics Centre which uses leading CRISPR methodologies.
Early Therapy Award – This award can provide funding of up to £350K for 18 – 24 months.
It is focused on:
- hit identification enabling work
- experimental assessment of druggability (e.g. by fragment screening)
- further development of an early therapeutic project
Due date: 25 September 2026
For more information click: https://www.cancerresearchuk.org/for-researchers/apply-for-and-manage-your-funding/our-funding-schemes/therapeutic-catalyst
New Supporting STISA 2034: SGCI Multilateral Research Call advancing Africa’s Science, Technology and Innovation priorities
The SGCI Multilateral Research Call in support of STISA-2034 will fund collaborative, multi-country research projects that advance Africa’s science, technology and innovation priorities and contribute to sustainable development outcomes across the continent. The call supports research aligned with five thematic streams:
Agriculture, Health, Artificial intelligence and Digital technologies, Energy, Environment. Through this call, the Science Granting Councils Initiative (SGCI) seeks to: Support high-quality research that addresses regional development challenges, Strengthen cross-border partnership, Promote the use of evidence in policy and practice. Consortia must include institutions from multiple participating SGCI countries and demonstrate how their proposed research contributes to national and continental priorities.
Due date: September 25, 2026 – 23:59 ET
For more information click: https://idrc-crdi.ca/en/funding/supporting-stisa-2034-sgci-multilateral-research-call-advancing-africas-science-technology
New CIPHER Research Grant Programme 2026/2027
This programme awards early-stage investigators up to USD 140,000 over two years to address research gaps in paediatric and adolescent HIV in countries with limited resources for HIV research. It is designed to provide investigators with the experience they need to compete for larger funding opportunities. This round will focus on priority areas in paediatric and adolescent HIV prevention and co-morbidities. Within HIV prevention, priority will be given to the prevention of vertical transmission and HIV prevention among adolescents and young people. The co-morbidities focus will include cardiometabolic conditions and key co-infections, particularly hepatitis and tuberculosis.
Due date: 30 September 2026, 18:00 CEST.
For more information click: https://www.iasociety.org/grants/cipher-grant-programme-2026-2027
New Apply for Funding from the CMT Research Foundation
The mission of the CMT Research Foundation is to deliver treatments and cures for CMT during our lifetime. The CMT Research Foundation pursues this goal by identifying and bridging the gaps in biomedical research, with a focus on areas that are most likely to result in clinical treatments. Funding is provided to the most promising research for CMT that leads to the development of therapeutics for all types of CMT. The research priorities drive funding decisions, however, if an interesting approach or idea, they would want to hear from you. Typical awards will range from $100,000 to $200,000 per year, based on stage and scope of research. Exceptional proposals with higher budgets are also considered. For studies requiring additional support, co-funding from other funding agencies, companies or investors is encouraged. Before submitting a full proposal, applicants must first submit a Letter of Intent.
For more information click; https://cmtrf.org/apply/
New Nestlé Foundation Research Grants
The Nestlé Foundation provides a range of research grants designed to strengthen scientific capacity and generate evidence-based solutions that improve maternal, child, and adolescent nutrition in low- and middle-income countries (LMICs). Our modular funding approach allows researchers to advance from smaller pilot or training studies to larger, impactful research programs. The eligibility criteria as well as the Research objectives and topics have to be fulfilled independently from the award category (for further details see section “Specific information for applications”):Training Grant; Pilot Grant; Regular Research Grant
Due date for Letter of Intent: N/A
For more information click; https://www.nestlefoundation.org/research
New Wellcome Early-Career Awards
This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme. You can apply to this scheme if you are an early-career researcher and you are ready to design, plan and deliver your own innovative research project that aims to: advance understanding in your field
and/or develop methodologies, conceptual frameworks, tools or techniques that could benefit health-related research.
Due date: There are no deadlines for applications to this scheme. Applications can be submitted at any time.
For more information click; https://wellcome.org/research-funding/schemes/wellcome-early-career-awards
New Wellcome Career Development Awards
This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing. You can apply for a Wellcome Career Development Award if you are a mid-career researcher and you are ready to lead a substantial and innovative research programme. You must aim to make a key contribution to your field by: generating significant shifts in understanding and/or developing methodologies, conceptual frameworks, tools or techniques that could benefit health-related research.
Due date: There are no deadlines for applications to this scheme. Applications can be submitted at any time.
For more information click; https://wellcome.org/research-funding/schemes/wellcome-career-development-awards
AthenaBIO funds women’s health research
We source, fund, govern, support, and incubate translational research in women’s health.nWe believe in a systems biology approach to research. However, to best evaluate the science we take a cohort approach to funding projects. Our first cohorts; Ovarian Aging, Menopause, Gynecologic Cancers, Polycystic Ovary Syndrome, Fertility, Endometriosis & Uterine Fibroids
Due date: Out-of-cohort, ongoing applications are open.
For more information click; https://www.athenadao.co/for-researchers
Curative Therapies for Fragile X: Advancing Gene and Protein Treatments
The Curative Therapies Research provides funding for researchers worldwide to promote accelerated development of curative therapies for Fragile X, including – but not limited to – gene therapy, gene repair, gene reactivation, protein replacement, mRNA therapeutics and targeted ASO treatments. The Curative Therapies Research Program offers flexible grants of up to $100,000 per year. There are no rigid structures. Projects can support principal investigators, trainees, supplies, or specialized tools, as long as the focus is clear: developing effective therapies for Fragile X.
Due date: Applications accepted on a rolling basis.
For more information click; https://www.fraxa.org/fragile-x-research/grant-application/#___Curative_Therapies_Research_is_High_Priority__
Sleep Research Society Foundation Mentored Collaboration Grant
The SRSF Mentored Collaboration Grant supports trainees who have limited sleep or circadian mentoring options in their chosen field of interest to mentors who can provide rich, face-to-face opportunities in state-of-the-art research techniques and methods. The mentor-mentee relationship is expected to extend beyond the face-to-face portion through ongoing phone or web-based meetings over the course of the funded year, with the goal of producing a research product such as an abstract for the SLEEP Meeting, a manuscript, and/or a grant proposal. The collaboration may take place in the United States or abroad, provided both participants remain active Sleep Research Society (SRS) Members.
Due date: Applications accepted on a rolling basis.
For more information click; https://sleepresearchsociety.org/awards/srsf-mentored-collaboration-grant/
Gilead – Giving in Africa
Our grantmaking in Africa focuses on the following therapeutic areas are HIV/AIDS and Viral Hepatitis. Within these therapeutic areas, we provide support for a broad range of activities, including:
- Disease awareness
- Disease prevention
- Professional education
- Improving patient access to care
- Improving quality of care
- Increasing scientific capacity
- Strengthening healthcare systems
Due date: Grant applications are accepted year-round. Keep in mind that you must submit the application at least six weeks before your activity begins, and that it typically takes approximately six to 12 weeks for review.
For more information click; https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-africa
New Call For Expression of Interest (EOI): AMBSO IMPACT RESEARCH INITIATIVE
The AMBSO Impact Research Initiative seeks to identify, fund, and accelerate innovative early-stage research, proof of concept projects, and emerging ideas with the potential to generate high-impact evidence, transformative scientific discoveries and scalable solutions to priority health challenges. The initiative supports bold and innovative ideas from researchers, academic institutions, community-based organizations, and other eligible entities whose work can directly inform policy, strengthen health systems and programs, improve population health outcomes, and reduce health risks. Priority will be given to applications focusing on the following tracks:
Track 1: Infectious diseases and global health security:
Track 2: Applying Artificial Intelligence (AI) in one of the following:
Track 3: HIV/AIDS epidemiological research: Integration and evaluation of Pre-Exposure Prophylaxis (PrEP) for HIV prevention.
Track 4: Climate change and Health: Effects of extreme weather events on disease transmission, adaptation and resilience strategies.
Track 5: Cancer research
Track 6: Maternal, child and adolescent health
Track 7: Non-communicable diseases:
Track 8: Health aging and Health
Due date for Expression of Interest: 2 October 2026
For more information click; https://www.ambso.org/opportunities/grants/call-for-expression-of-interest-eoi-ambso-impact-research-initiative
Seeding Labs Apply for Equipment
At Seeding Labs, we equip scientists everywhere to lead the way to brighter and healthier futures Through Instrumental Access, Seeding Labs connects universities and research institutes in low- and middle-income countries with high-quality laboratory equipment.
Due date: You can submit your application at any time, but these are the upcoming dates when applications will be reviewed: 16 October 2026
For more information click; https://seedinglabs.org/instrumental-access-application/
New Innovations in Low-Cost and Simplified Pathogen Sequencing Workflows
This Grand Challenge is co-funded by the Gates Foundation, and the Temasek Foundation, and will be managed by the United Nations Foundation. This Grand Challenge is implemented in collaboration with a network of global and regional partners, including International Pathogen Surveillance Network (IPSN), hosted by the WHO Hub for Pandemic and Epidemic Intelligence, the Africa Pathogen Genomics Initiative (Africa PGI), and the Asia Pathogen Genomics Initiative (Asia PGI) as regional technical and public-health partners. This RFP aims to accelerate the development of affordable, scalable, and operationally simple sequencing solutions, enabling routine use of genomics for public health in low- and middle-income countries (LMICs). If you are planning to apply to this RFP, we will be hosting a dedicated webinar on September 1, 2026, from 5:30-6:30 AM Pacific Time. This session will provide a comprehensive overview of the RFP details and an opportunity to answer your questions. To participate in the webinar, please register and submit your questions in advance.
Due date: September 29, 2026, 11:30 am PDT
For more information click; https://gcgh.grandchallenges.org/challenge/innovations-low-cost-and-simplified-pathogen-sequencing-workflows
Velux Stiftung Ophthalmology Institutional Research Capacity Strengthening Grant Program
The Velux Stiftung has launched the Ophthalmology Institutional Research Capacity Strengthening Grant Program to support long-term biomedical and clinical ophthalmology research development in low- and middle-income countries (LMICs). The program focuses on strengthening institutional research systems, leadership, infrastructure, and sustainable ophthalmology research ecosystems. The initiative supports collaborative projects that help LMIC institutions build lasting research capacity, develop centres of excellence, and improve institutional structures for ophthalmology research and innovation.
Due date: 01 October 2026, 23:59 CEST
For more information click: https://veluxstiftung.ch/funding-areas/ophthalmology/
New GenScript Life Science Research Grant (GenScript LSRG)
The GenScript Life Science Research Grant (GenScript LSRG) is the global initiative for life science innovation,
providing $1.5 million in annual funding to support researchers shaping the future of life science. Many promising ideas face real challenges, not because they lack merit, but because researchers may have limited access to funding, infrastructure, and the right scientific ecosystem. By combining funding, scientific expertise, and global ecosystem access, GenScript LSRG helps ideas develop, scale, and move toward real-world impact whether you’re advancing AI-powered drug discovery, antibody engineering, cell and gene therapies, vaccines, diagnostics, biologics, or other research areas. What is offered;
- Global Pioneer Grant up to $500,000
- Rising Star Grant up to $50,000
- AI Drug Discovery Frontier Grant up to $100,000
Due date: 6 October, 2026
For more information click; https://www.genscript.com/lsrg-program.html
New ASCO Career Development Award
The Career Development Award (CDA) provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. The research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. Applications in all areas of cancer research are accepted from U.S. and international applicants.
Due date: 8 October, 2026
For more information click; https://www.asco.org/career-development/grants-awards/funding-opportunities/career-development-award
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
The purpose of this engineering-oriented notice of funding opportunity (NOFO) announcement is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. This NOFO will support clinical trials that test functionality or validate performance in the chosen setting. Applications that propose phase III clinical trials are not sought by and will not be supported through this NOFO.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-233.html
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-143.html
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites Small Research Grant (R03) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data or the secondary analysis of existing data. Applications may propose studies using either single or mixed methods. Applied research designed to address ELSI issues in genetics and genomics will also be considered responsive. Direct engagement with communities and other stakeholders is encouraged, but not required.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-370.html
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. Applications may propose studies using either single or mixed methods, that break new ground, extend previous discoveries in new directions, or develop preliminary data in preparation for larger studies. Approaches may include but are not limited to empirical qualitative and quantitative methods, and conceptual, legal, and normative analyses. Applied research designed to address ELSI issues in genetics and genomics will also be considered responsive. Direct engagement with communities and other stakeholders is encouraged, but not required.
Due date: October 20, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-369.html
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empirical qualitative and quantitative methods, and conceptual, legal, and normative analyses. Applied research designed to address ELSI issues in genetics and genomics will also be considered responsive. Direct engagement with communities and other interested groups is encouraged, but not required.
Due date: October 20, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-371.html
New TANGO2 Research Foundation (T2RF) research grants-Grant Cycle Seven
The TANGO2 Research Foundation (T2RF) research grants provides essential funding for seed or pilot research projects, fostering the exploration of groundbreaking research concepts. These awards support initial testing phases, allowing researchers to embark on smaller-scale endeavors. The emphasis lies in evaluating feasibility and refining methodologies, shaping the trajectory of potential larger-scale studies. Through this funding mechanism, we empower researchers to take innovative ideas from conception to a vital stage of validation, contributing to the advancement of knowledge and discovery. We seeks to fund rigorous, high-quality research studies in efforts to fulfill our foundation’s mission enthusiastically.
T2RF funds two types of Research Grants:
- Single-Institution – This grant supports a research initiative within a single institution that may or may not involve multiple research investigators and/or a multi-departmental research team.
- Multi-Institution – This grant supports a collaborative research initiative which requires the PI/PD to partner with an institution or personnel outside of their own academic/research institution, and/or affiliated hospital institution.
Due date Letter of Intent: 6 November, 2026, 5:00 pm EST
For more information click; https://tango2research.org/research/grants/
New DKMS John Hansen Research Grant 2027
The DKMS John Hansen Research Grant awards € 240,000 for a time period of three years (maximum € 80,000 annually), subject to reasonable progress of the research. Up to four projects will be selected from the eligible applications. The research proposal needs to address issues on hematopoietic stem cell transplantation or cell therapy for hematological diseases. Various aspects can be covered, including but not limited to: diagnostic and therapeutic strategies, transplant immunology, stem cell transplantation complications, donor selection, or cell manufacturing.
Due date: November 16, 2026, 23:59h (Central European Time).
For more information click; https://professional.dkms.org/research-publications/research-grant
New Rising Tide Foundation for Clinical Cancer Research (RTFCCR)
RTFCCR invites academic institutions and not-for-profit organizations to collaborate on innovative, patient-centered clinical trials. Our mission is to improve cancer patients’ treatment options and quality of life by funding studies focused on detection, treatment, and implementation.We support phase I to phase III interventional clinical trials but do not fund basic research, phase IV trials, or observational studies. Funding is available to institutions worldwide where effective grant oversight is feasible.
Due date letter of Intent: 23 November, 2026, 23:59 CET
For more information click; https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/
New Gut Microbiota International Call for Projects
The Biocodex Microbiota Foundation founds research projects focused on human gut microbiota related to health and disease. Every year, the call for proposals covers a specific theme chosen by an International Scientific Committee. Either clinical or fundamental research proposals can be submitted. The maximal duration of the project will be 3 years.
Due date: 30 November, 2026 (24:CET)
For more information click; https://www.biocodexmicrobiotafoundation.com/international-research-grant/international-call-projects
The Biocodex Microbiota Foundation Gut Microbiota International Call for Projects
The Biocodex Microbiota Foundation funds research projects focused on human gut microbiota related to health and disease. Every year, the call for proposals covers a specific theme chosen by an International Scientific Committee. Either clinical or fundamental research proposals can be submitted. The maximal duration of the project will be 3 years. The project should involve Microbiome analysis, Immunophenotyping and a dietary component. The project should be primarily performed in humans and in a disease context (Studies purely on healthy subjects are excluded). Pure observational studies should be avoided and some experimental validation is expected.
Due date: 30 November, 2026
For more information click; https://www.biocodexmicrobiotafoundation.com/international-research-grant/international-call-projects
New 2027 AABB Foundation Early-Career Scientific Research Grants
The AABB Foundation awards grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine and biotherapies. Grant applications are evaluated on the basis of their scientific merit, relevance to and impact on transfusion medicine, focus and appropriateness to the scope of funding, and likelihood of yielding meaningful data.
Due date: 1 December 2026
For more information click; https://www.aabb.org/foundation/early-career-scientific-research-grants-program
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
The goal of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to a low- or middle-income country (LMIC) early career research scientist who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries, with exceptions below (see Section III. Eligibility Information)). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Notice of Funding Opportunity (NOFO) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.
Due date: 3 December 2026
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-295.html
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
The goal of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to a low- or middle-income country (LMIC) early career research scientist who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries, with exceptions below (see Section III. Eligibility Information)). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Notice of Funding Opportunity (NOFO)invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.
Due date: 3 December 2026
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-296.html
Fellowships and Scholarships
GloCal Health Fellowship
The GloCal Health Fellowship provides aspiring global health researchers with outstanding interdisciplinary education and training in innovative research designed to improve health for populations around the world. A career development fellowship sponsored by the National Institutes of Health (NIH) Fogarty International Center (FIC), this program supports awarded fellows from all 10 UC campuses as well as 29 affiliated international sites across 22 countries. UCGHI manages and supports the GloCal Health Fellowship. Ideal candidates will propose research in areas such as, but not limited to:
- HIV
- Infectious Diseases
- Noncommunicable Diseases
- Global Surgery
- Cancer
- Mental Health and Addiction
- Sexual and Reproductive Health
- Planetary Health
Due date: September 15, 2026, 3:00 pm PST
For more information click: https://ucghi.universityofcalifornia.edu/fellowships/glocal-health-fellowship/application-process/
New The Schlumberger Foundation Faculty for the Future Fellowship
Applications for 2027 PhD and Post-Doc funding for women engineers and scientists from the world’s developing and emerging economies will open in September 2026. This year, we are particularly keen to see applications from the following academic disciplines: Physical Sciences, Engineering, Computer Science and Mathematics. To apply, you must:
- Be a woman from an eligible low- or middle-income country.
- Be pursuing a PhD or post-doctoral research in a STEM field.
- Be enrolled, admitted, or have applied to a university or research institute abroad.
- Have an excellent academic record.
- Be committed to returning to your home country to contribute to its socio-economic development.
- Demonstrate leadership, community engagement, and a track record of encouraging women and girls in STEM.
Due date: 6 November 2026
For more information click: https://schlumbergerfoundation.com/applications-for-2026/
New Harvard Learn, Engage, Advance, Disrupt “LEAD” Fellowship for Promoting Women in Global Health
To equip and empower more leaders in global health, the Harvard Global Health Institute, in collaboration with the Department of Global Health and Population at Harvard T.H. Chan School of Public Health, offers a transformational 1-year fellowship specifically designed to promote leadership skills in individuals in low- and middle-income countries who will, in turn, mentor future female leaders in global health. Candidates should be currently based/working in a LMIC, and plan to return there after their fellowship.
Applications for the 2027 – 2028 cohort will open in September 2026. Once open, we will collect applications for 8 weeks.
For more information, click: https://globalhealth.harvard.edu/fellowships/harvard-lead-fellowship/
New McDonald Fellowships
The McDonald Fellowship enables early career multiple sclerosis researchers from low- and middle-income countries to work in a research institution outside of their own country. During the visit, participants either gain expertise or carry out parts of joint research projects. Following the award, we expect applicants will be able to use the newly developed expertise and networks, continuing to undertake MS research and/or patient care in low- and middle-income countries. Fellowship projects that focus on topics with clear benefits for people with MS in low- and middle-income countries will be prioritised. The fellowship payment is a two-year grant, consisting of 55,000 EUR per year, paid to the host institution and then used to pay the fellow. One return flight to the host country will also be covered by the Fellowship.
Due date: 1 December 2026
For more information click: https://www.msif.org/research/awards-grants-and-fellowships/mcdonald-fellowships/
New AthenaBIO funds women’s health research
We source, fund, govern, support, and incubate translational research in women’s health.nWe believe in a systems biology approach to research. However, to best evaluate the science we take a cohort approach to funding projects. Our first cohorts; Ovarian Aging, Menopause, Gynecologic Cancers, Polycystic Ovary Syndrome, Fertility, Endometriosis & Uterine Fibroids
Due date: Out-of-cohort, ongoing applications are open.
For more information click; https://www.athenadao.co/for-researchers
New Curative Therapies for Fragile X: Advancing Gene and Protein Treatments
The Curative Therapies Research provides funding for researchers worldwide to promote accelerated development of curative therapies for Fragile X, including – but not limited to – gene therapy, gene repair, gene reactivation, protein replacement, mRNA therapeutics and targeted ASO treatments. The Curative Therapies Research Program offers flexible grants of up to $100,000 per year. There are no rigid structures. Projects can support principal investigators, trainees, supplies, or specialized tools, as long as the focus is clear: developing effective therapies for Fragile X.
Due date: Applications accepted on a rolling basis.
For more information click; https://www.fraxa.org/fragile-x-research/grant-application/#___Curative_Therapies_Research_is_High_Priority__
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Current recipients of specific types of NIH research grants may apply for administrative supplements, using this Notice of Funding Opportunity (NOFO), to provide additional funding to a currently funded grant to meet increased costs that are within the scope of the peer-reviewed and approved project, but that were unforeseen when the new or competing renewal application was awarded. Applications for administrative supplements are considered prior approval requests (as described in Section 8.1.2.11 of the NIH Grants Policy Statement) and will be routed directly to the Grants Management Officer of the parent award. There is no guarantee that funds are available from the awarding IC or for any specific grant. Therefore, prior to submission, applicants must discuss potential requests with the awarding ICO grants and program officials.
For more information click; https://files.simpler.grants.gov/opportunities/bd113473-bd20-4739-95e0-51131671558a/attachments/fad88583-05c7-4b0b-a1b1-8a289438e3ce/PA-26-001-Full-Announcement.html
New SVRI Data to Evidence Grant 2027: Knowledge for Action to End Violence Against Women and Child Sexual Violence
The SVRI’s Data to Evidence Grant 2027 supports researchers based in low- and middle-income countries to analyse data that has already been collected, generating new evidence to answer questions the field has not yet resolved. The Data to Evidence Grant will fund LMIC-based researchers to conduct secondary data analyses, generating new evidence on questions the field has not yet answered and putting it in the hands of researchers, policymakers and practitioners. SVRI will also provide technical assistance and mentorship, strengthening the skills of researchers in secondary data analysis that then can apply to other datasets in the future. Applicants may propose analysis of any dataset relevant to VAW and CSV provided the dataset has been ethically sourced and the applicant can demonstrate they have the necessary approval to use it. A number of existing datasets relevant to the field are listed on SVRI’s datasets page. Applicants are encouraged to consult this page, though use of a dataset not listed there is equally welcome, provided it meets the ethical sourcing and approval requirements set out below.
Due date: 17 September 2026, 11:59 pm (South African time)
For more information click: https://www.svri.org/svri-research-grant/?#apply-for-svri-research-grant
Wellcome Discovery Awards
This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.
Due date: 22 September 2026, 15:00 BST
For more information click: https://wellcome.org/research-funding/schemes/wellcome-discovery-awards
New Therapeutic Catalyst
This scheme provides opportunities to accelerate the translation of laboratory discoveries into novel cancer therapeutics. Projects are run collaboratively by an academic laboratory and Cancer Research Horizons’ team of over 180 experienced drug discovery scientists. Before making an application, we strongly recommend that you discuss the project with a member of our Therapeutic Translation team within Cancer Research Horizons. They can support you with advice on the available schemes and the application process. You must first submit an expression of interest making it clear which award you are applying for (i.e. Target or Early Therapy). An internal cross-functional committee will triage and review the therapeutic potential of the project and feasibility for eligibility and strategic fit. If successful, you will be invited to submit a full project proposal.
Due date: 25 September 2026
Velux Stiftung Ophthalmology Institutional Research Capacity Strengthening Grant Program
The Velux Stiftung has launched the Ophthalmology Institutional Research Capacity Strengthening Grant Program to support long-term biomedical and clinical ophthalmology research development in low- and middle-income countries (LMICs). The program focuses on strengthening institutional research systems, leadership, infrastructure, and sustainable ophthalmology research ecosystems. The initiative supports collaborative projects that help LMIC institutions build lasting research capacity, develop centres of excellence, and improve institutional structures for ophthalmology research and innovation.
Due date: 01 October 2026, 23:59 CEST
For more information click: https://veluxstiftung.ch/funding-areas/ophthalmology/
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
The purpose of this engineering-oriented notice of funding opportunity (NOFO) announcement is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. This NOFO will support clinical trials that test functionality or validate performance in the chosen setting. Applications that propose phase III clinical trials are not sought by and will not be supported through this NOFO.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-233.html
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-143.html
New Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites Small Research Grant (R03) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data or the secondary analysis of existing data. Applications may propose studies using either single or mixed methods. Applied research designed to address ELSI issues in genetics and genomics will also be considered responsive. Direct engagement with communities and other stakeholders is encouraged, but not required.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-370.html
New Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. Applications may propose studies using either single or mixed methods, that break new ground, extend previous discoveries in new directions, or develop preliminary data in preparation for larger studies. Approaches may include but are not limited to empirical qualitative and quantitative methods, and conceptual, legal, and normative analyses. Applied research designed to address ELSI issues in genetics and genomics will also be considered responsive. Direct engagement with communities and other stakeholders is encouraged, but not required.
Due date: October 20, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-369.html
New Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empirical qualitative and quantitative methods, and conceptual, legal, and normative analyses. Applied research designed to address ELSI issues in genetics and genomics will also be considered responsive. Direct engagement with communities and other interested groups is encouraged, but not required.
Due date: October 20, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-371.html
The Biocodex Microbiota Foundation Gut Microbiota International Call for Projects
The Biocodex Microbiota Foundation funds research projects focused on human gut microbiota related to health and disease. Every year, the call for proposals covers a specific theme chosen by an International Scientific Committee. Either clinical or fundamental research proposals can be submitted. The maximal duration of the project will be 3 years. The project should involve Microbiome analysis, Immunophenotyping and a dietary component. The project should be primarily performed in humans and in a disease context (Studies purely on healthy subjects are excluded). Pure observational studies should be avoided and some experimental validation is expected.
Due date: 30 November, 2026
For more information click; https://www.biocodexmicrobiotafoundation.com/international-research-grant/international-call-projects
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
The goal of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to a low- or middle-income country (LMIC) early career research scientist who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries, with exceptions below (see Section III. Eligibility Information)). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Notice of Funding Opportunity (NOFO) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.
Due date: 3 December 2026
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-295.html
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
The goal of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to a low- or middle-income country (LMIC) early career research scientist who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries, with exceptions below (see Section III. Eligibility Information)). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Notice of Funding Opportunity (NOFO)invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.
Due date: 3 December 2026
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-296.html
Fellowships and Scholarships
Cancer Prevention Fellowship Program
Established in 1987, the NCI Cancer Prevention Fellowship Program (CPFP) supports postdoctoral fellows from diverse fields for up to four years of mentored research and career development, including a Master of Public Health (MPH) degree for those without prior public health training. The program accepts U.S. citizens, permanent residents, and eligible international applicants from low- and middle-income countries (LMICs).
Due date: August 6, 2026
For more information click: https://trainatnci.cancer.gov/programs/cpfp/
New Schizophrenia Research Fellowship
The MQ Mental Health Research Schizophrenia Research Fellowship supports early career scientists from across the globe in research that improves understanding, prevention, diagnosis and/or treatment of schizophrenia. Applications are open to mental health researchers who have between 3 and 7 years of postdoctoral experience. Candidates must be based at a university, hospital, or other independent research organizations located anywhere in the world, except those based in countries currently under UK financial sanctions.
Due date: August 12, 2026
For more information click: https://www.mqmentalhealth.org/schizophrenia-research-fellowship/
New CRI Immuno-Informatics Postdoctoral Fellowship
Cultivating the Next Generation of Leaders at the Intersection of Immunology and Data Science. The CRI Immuno-Informatics Postdoctoral Fellowship Program supports outstanding early-career scientists worldwide who seek dual expertise in immunology and data science. This unique program fosters a new generation of researchers fluent in both biology and computation, equipping them to drive innovation in cancer immunotherapy. The CRI Immuno-Informatics Fellowship is designed to support:
- Computational biologists seeking to deepen their understanding of immunology
- Cancer immunologists aiming to gain expertise in computational biology, data science, and/or genomics
- Researchers from diverse PhD backgrounds pursuing training at the interface of cancer immunology and computational biology
Due date: Applications 1 September 2026 11:59 p.m. Eastern Time.
For more information click: https://www.cancerresearch.org/immuno-informatics-postdoctoral-fellowship
GloCal Health Fellowship
The GloCal Health Fellowship provides aspiring global health researchers with outstanding interdisciplinary education and training in innovative research designed to improve health for populations around the world. A career development fellowship sponsored by the National Institutes of Health (NIH) Fogarty International Center (FIC), this program supports awarded fellows from all 10 UC campuses as well as 29 affiliated international sites across 22 countries. UCGHI manages and supports the GloCal Health Fellowship. Ideal candidates will propose research in areas such as, but not limited to:
- HIV
- Infectious Diseases
- Noncommunicable Diseases
- Global Surgery
- Cancer
- Mental Health and Addiction
- Sexual and Reproductive Health
- Planetary Health
Due date: September 15, 2026, 3:00 pm PST
For more information click: https://ucghi.universityofcalifornia.edu/fellowships/glocal-health-fellowship/application-process/
Notices
NIH Common Forms Requirements
NIH has adopted the Common Forms as per the White House Office of Science and Technology Policy (OSTP) memorandum on Policy Regarding Use of Common Disclosure Forms. NIH implemented the Biographical Sketch Common Form and the Current and Pending (Other) Support Common Form for Research Performance Progress Reports (RPRRs) and application submissions on or after January 25, 2026. Use of the Common Forms and NIH Biographical Sketch Supplement will be required for all application due dates and Just-In-Time (JIT), Research Performance Progress Report (RPPR), and Prior Approval submissions on or after May 8, 2026. On that date, system warnings will change to errors that will stop any submission not using compliant Common Forms.
For more information on the Announcement, click; https://grants.nih.gov/grants/guide/notice-files/NOT-OD-26-079.html
Reminder – Definition of Foreign Components
NIH has recently received questions regarding whether there has been a change in the definition of a foreign component, and whether a foreign co-author on a publication that cites an NIH grant award automatically results in a foreign component. This notice reminds the extramural community of NIH’s longstanding definition of foreign components.
For more information, click; https://grants.nih.gov/grants/guide/notice-files/NOT-OD-26-084.html
New Gilead – Giving in Africa
Our grantmaking in Africa focuses on the following therapeutic areas are HIV/AIDS and Viral Hepatitis. Within these therapeutic areas, we provide support for a broad range of activities, including:
- Disease awareness
- Disease prevention
- Professional education
- Improving patient access to care
- Improving quality of care
- Increasing scientific capacity
- Strengthening healthcare systems
Due date: Grant applications are accepted year-round. Keep in mind that you must submit the application at least six weeks before your activity begins, and that it typically takes approximately six to 12 weeks for review.
For more information click; https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding/giving-in-africa
Seeding Labs Apply for Equipment
At Seeding Labs, we equip scientists everywhere to lead the way to brighter and healthier futures Through Instrumental Access, Seeding Labs connects universities and research institutes in low- and middle-income countries with high-quality laboratory equipment.
Due date: You can submit your application at any time, but these are the upcoming dates when applications will be reviewed: 14 August 2026 or 16 October 2026
For more information click; https://seedinglabs.org/instrumental-access-application/
Call for Proposals: Development Innovation Ventures (DIV) Fund
We accept proposals from all organization types operating in any sector or geography within low- and middle-income countries, across a wide range of solution types and paths to scale, including both commercial and public-sector adoption. We offer three award tiers – Stage 1 (Piloting), Stage 2 (Testing), and Stage 3 (Scaling) – with requirements calibrated according to the strength of the evidence of impact, cost-effectiveness, and the potential for durable scale of the proposed innovation. Applicants should apply for the stage that best reflects the current state of development of the innovation and its readiness to generate stronger evidence and prepare for scale. While you do not need to start at Stage 1, if applying for later stage awards, your application should credibly demonstrate that you have already met the criteria for earlier stages.
Due date: Applications are accepted on a rolling basis.
For more information click; https://www.div.fund/apply#how-to-apply
New Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Current recipients of specific types of NIH research grants may apply for administrative supplements, using this Notice of Funding Opportunity (NOFO), to provide additional funding to a currently funded grant to meet increased costs that are within the scope of the peer-reviewed and approved project, but that were unforeseen when the new or competing renewal application was awarded. Applications for administrative supplements are considered prior approval requests (as described in Section 8.1.2.11 of the NIH Grants Policy Statement) and will be routed directly to the Grants Management Officer of the parent award. There is no guarantee that funds are available from the awarding IC or for any specific grant. Therefore, prior to submission, applicants must discuss potential requests with the awarding ICO grants and program officials.
For more information click; https://files.simpler.grants.gov/opportunities/bd113473-bd20-4739-95e0-51131671558a/attachments/fad88583-05c7-4b0b-a1b1-8a289438e3ce/PA-26-001-Full-Announcement.html
Michelson Prizes: Next Generation Grants
Michelson Prizes: Next Generation Grants are $150,000 research grants given annually to support promising researchers applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases. The committee will look for research that aims to tackle the current roadblocks to human vaccine development and expand our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. While the Michelson Prizes are focused on research in the fields of immunology, vaccine, and immunotherapy discovery, applicants from the full spectrum of related disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, nanotechnology, etc., are encouraged to apply.
Due date: June 22, 2026, 11:59 pm EDT (UTC-4)
For more information click; https://www.michelsonmedicalresearch.org/michelson-prizes-next-generation
New Quarterly Research Grant Funding Programme
This programme funds preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s. We do not fund research which is directed at symptomatic relief. For preclinical research, we fund grants up to £250,000 (GBP) and prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, we fund clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible, so please contact us ahead of submission if you are thinking of applying for a clinical trial.
Due date: June 22, 2026, 23:59pm BST
For more information click; https://cureparkinsons.org.uk/research/for-researchers/apply-for-funding/quarterly-research-grant/
NIHR Global Health Research Professorships (Cohort 9)
The Global Health Research Professorships award is a professorial-level funding opportunity. You can apply if you are an outstanding academic who is on track to become a future Global Health research leader. The award promotes effective translation of research. This award will fund up to £2,000,000 over 5 years to undertake a research project, cover salary costs, training and development, and institutional capacity strengthening in LMICs. Your proposed research project must be within our Global Health Research remit for career development awards. Your application must focus on addressing global health security threats and challenges, improving the ability of health systems to protect the health of the poorest and most vulnerable in sub-Saharan Africa and South Asia. This, includes maternal, newborn, child, and adolescent health.
Due date: 30 June 2026 at 1:00 pm.
For more information, click: https://www.nihr.ac.uk/funding/global-health-research-professorships-cohort-9/2026423
Request for Proposals: Clinical Cancer Research Grant Program
The Clinical Cancer Research Grant Program supports patient-focused interventional clinical trials in cancer research. The goal is to advance clinical studies that can directly improve outcomes for patients by:
- Optimizing cancer therapies
- Reducing disease and treatment burden
- Supporting earlier detection and intervention
- Improving quality of life during and after treatment
The programme is specifically intended for interventional clinical trials and does not support basic or purely observational research.
Due date: June 22, 2026, 23:59 CET
For more information click; https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/
NIHR Tackling bacterial and fungal antimicrobial resistance in sub-Saharan Africa and South Asia
Our 2026 Global Health Research theme is antimicrobial resistance (AMR), with a focus on bacterial and fungal pathogens on the World Health Organisation (WHO) priority lists. This choice of theme was informed by existing areas of need, including those identified by the WHO Global Research Agenda for AMR, horizon scanning and a consultation with key stakeholders. It was further refined by experts from an independent scientific advisory group.
This process highlighted a lack of evidence on real-world implementation of interventions designed to:
- strengthen antimicrobial stewardship
- prevent AMR infections
- improve AMR-related health outcomes
This is a 2-stage, researcher-led funding opportunity. To apply for the first stage, you should submit an outline application. If invited to the second stage, you will then need to complete a full application.
Due date: 8 July 2026 at 1:00 pm
For more information click; https://www.nihr.ac.uk/funding/tackling-bacterial-and-fungal-antimicrobial-resistance-sub-saharan-africa-and-south-asia/2026402
New Spencer Foundation – Research-Practice Partnerships: Collaborative Research for Educational Change
The Research-Practice Partnership (RPP) Grants Program is intended to support education research projects that engage in collaborative and participatory partnerships with project budgets up to $400,000 and durations of up to three years. We accept preproposals once a year in this program. We view partnerships as an important approach to knowledge generation and the improvement of education, broadly construed. Over the long term, we anticipate that research conducted by RPPs will result in new insights into the processes, practices, and policies that improve education for learners, educators, families, communities, and institutions where learning and teaching happen (e.g., schools, universities, community centers, parks, museums, other workplaces).
Due date for Pre-proposal: July 10, 2026, 12:00 PM Noon (Central/Chicago Time)
For more information click; https://www.spencer.org/grant_types/research-practice-partnerships
E.W. “Al” Thrasher Awards
E.W. “Al” Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States. Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority. Hypothesis-driven research is critical, exploratory, or hypothesis-generating research will not be competitive. For projects focused on improving disease diagnosis, please ensure that there are well researched, effective treatment options available to patients upon diagnosis.
Due date for Concept: 14 July 2026 (Noon Mountain Time)
For more information click; https://www.thrasherresearch.org/al-thrasher-award?lang=eng
Mental Health Award: Using physical activity and circadian-based interventions to reduce anxiety and depression in young people
This award will fund mechanistically informed trials of interventions for anxiety and depression in young people aged 10-18 years. Successful teams will build on existing mechanistic evidence to develop more precise and effective early interventions that have the potential to scale.
Due date: 14 July 2026, 15:00 BST)
For more information click; https://wellcome.org/research-funding/schemes/mental-health-award-using-physical-activity-and-circadian-based-0
John Templeton Foundation Grants for Interdisciplinary Research
The John Templeton Foundation supports interdisciplinary research and public engagement that inspire awe, wonder, and curiosity about the universe. Its funding encourages intellectual exploration while promoting lives of meaning, purpose, and ethical reflection. The Foundation’s grants span multiple areas:
- Character Virtue Development – Research and initiatives that promote moral and personal growth.
- Individual Freedom & Free Markets – Studies and programs that examine liberty, economic freedom, and societal impact.
- Life Sciences – Advancing understanding of biology, health, and human development.
- Mathematical & Physical Sciences – Support for fundamental research in physics, mathematics, and related fields.
- Public Engagement – Initiatives that make research accessible and meaningful to wider audiences.
- Religion, Science, and Society – Projects exploring the interaction between faith, scientific inquiry, and societal development.
Due date for Concept: 14 July 2026 (Noon Mountain Time)
For more information click; https://www.templeton.org/grants/grant-calendar
Wellcome Early-Career Awards
This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.
Due date: 21 July 2026, 15:00 BST
For more information click; https://wellcome.org/research-funding/schemes/wellcome-early-career-awards
Wellcome Career Development Awards
This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.
Due date: 28 July 2026, 15:00 BST
For more information click; https://wellcome.org/research-funding/schemes/wellcome-career-development-awards
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from low- and middle-income country (LMIC) and U.S. institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research (not including HIV/AIDS). FIC will support research training programs that focus on 1) major endemic or life-threatening emerging infectious diseases, 2) neglected tropical diseases, 3) infections that frequently occur as co-infections in HIV infected individuals or 4) infections or microbiomes associated with non-communicable disease conditions of public health importance in LMICs. Advanced scientific training related to prevention, treatment or public health approaches to any technical area of basic, epidemiological, clinical, behavioral or social science health research may be supported. Research training programs should incorporate didactic, mentored research and professional development skills components to prepare individuals for sustainable careers that will have significant impact on the priority health research needs of LMICs.
Due date: 6 August 2026
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-174.html
New The Spencer Foundation Vision Grant program
The Spencer Foundation invests in research to improve education, broadly conceived. We know that rigorous research can play a critical role in identifying systemic inequities, evaluating what actually works, and guiding evidence-based changes that make education systems fairer and more inclusive. The Vision Grant program provides scholars and collaborators with the time, space, resources, and support to plan a large-scale study or program of research: geared toward real-world impact to make education systems more equitable; drawing on research across disciplines and methods; and developed through meaningful and equitable collaboration with practitioners, policymakers, communities, and other partners; and focused on transforming educational systems.
Due date for Intent: August 12, 2026, 12:00 PM Noon (Central/Chicago Time)
For more information click: https://www.spencer.org/grant_types/vision-grants
New Upcoming funding opportunity – Addressing Neglected Areas of Sexual and Reproductive Health and Rights in sub-Saharan Africa
The Addressing Neglected Areas of Sexual and Reproductive Health and Rights in sub-Saharan Africa (ANeSA) initiative is issuing a preannouncement of an upcoming two-stage funding opportunity. The call of Letters of Interest is expected to launch on June 29, 2026. The initiative will support up to six additional Implementation Research Teams, with grants of up to CAD 1.2 million each. Up to 12 teams will be invited to submit full proposals in the second stage. ANeSA aims to support greater realization of neglected sexual and reproductive health and rights by under-served populations, including women and girls, men and boys, and gender diverse people, in sub-Saharan Africa. ANeSA five priority areas are:
- Improving access to family planning and contraceptive services
- Expanding access to safe abortion care, where legally permitted, and post-abortion care (APAC)
- Upholding SRHR rights and ensuring access to services for adolescents
- Preventing sexual- and gender-based violence (SGBV) and improving services for people experiencing SGBV
- Strengthening advocacy for SRHR
Due date for letters of interest: August 23, 2026 – 00:00 ET
New Global Public Health Awards for Early Career Investigators
The Global Public Health Awards support early career investigators from low- and middle-income countries working on HIV and viral hepatitis (B, C, and D). The programme funds independent research that strengthens country-driven public health priorities, particularly in prevention, implementation science, and disease management. Focus Areas
- HIV prevention, treatment, and management research
- Viral hepatitis (B, C, D) research and control strategies
- Implementation science and health systems research
- Public health innovation aligned with Sustainable Development Goals (SDGs)
- Cross-disciplinary research (economics, psychology, anthropology, engineering)
Due date: 28 Aug 2026, 11:59 PM CEST.
For more information, click: https://researchscholars.gilead.com/public_health/program-specifics/eligibility
Merck Stimulating Innovative Research Grant Program 2026
Since 2018, we have been offering research grants to encourage innovation in key areas that will shape the future. Grants of up to 500,000 € per year for up to 3 years have been made available. In 2026, grants are available in the areas further specified below.
- In-vitro models and assays to identify novel therapies for neuroinflammatory diseases – one grant of up to 250,000 EUR per year for up to 2 years.
- Artificial intelligence in cell culture media and process development – one grant of up to 150,000 EUR per year for up to 3 years.
- Innovative approaches to economical remediation of contaminated high volume materials – one grant of up to 150,000 EUR per year for up to 2 years.
- Condensate-based high-sensitivity cell-free screening assays for the modulation of protein-protein interactions – one grant of up to 100,000 EUR per year for up to 3 years.
- Advancing molecule synthesis and discovery – up to 3 grants each comprising a 1-year full Synthia® Retrosynthesis Software license, training, and extensive interaction with our scientists.
Due date: 31 August 2026
For more information click: https://www.merckgroup.com/en/research/open-innovation/research-grants.html
New Neurotorium Clinical Education Grants within Psychiatry and Neurology
Neurotorium Clinical Education Grants support non-profit educational projects for healthcare professionals in psychiatry and neurology. Neurotorium is an educational platform providing free and unbiased material for clinicians, educators, researchers, and all who are interested in learning about the brain. All our educational material is developed, reviewed, and regularly updated by leading experts. You can find more information about Neurotorium here. Neurotorium is offering Clinical Education Grants to support non-profit educational projects aimed at strengthening clinical competencies within the prevention, diagnosis, and treatment of psychiatric and neurological disorders through educational activities aimed at healthcare professionals.
We encourage applications from a diverse pool of applicants and especially encourage projects from, or serving, low-income countries.
Due date: 2 September 2026.
For more information click: https://neurotorium.org/grants/clinical-education-grant/
New Global Health EDCTP3 Calls for proposals
Global Health EDCTP3 invests in global health through funding collaborative research and innovation projects tackling infectious diseases and supporting activities for research capacity building in Africa.
- HORIZON-JU-GH-EDCTP3-2026-03-DIGIT-02 Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence
- HORIZON-JU-GH-EDCTP3-2026-03-SERP-01 Training and innovation networks for sustained capacity development related to ethics, regulatory, pharmacovigilance, and related digital regulatory platforms
Due date: 02 September 2026 17:00:00 Brussels time
For more information click: https://www.global-health-edctp3.europa.eu/funding/calls-proposals_en?f%5B0%5D=project_status_project_status%3A41#oe-list-page-filters-anchor
Wellcome Discovery Awards
This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.
Due date: 22 September 2026, 15:00 BST
For more information click: https://wellcome.org/research-funding/schemes/wellcome-discovery-awards
New Velux Stiftung Ophthalmology Institutional Research Capacity Strengthening Grant Program
The Velux Stiftung has launched the Ophthalmology Institutional Research Capacity Strengthening Grant Program to support long-term biomedical and clinical ophthalmology research development in low- and middle-income countries (LMICs). The program focuses on strengthening institutional research systems, leadership, infrastructure, and sustainable ophthalmology research ecosystems. The initiative supports collaborative projects that help LMIC institutions build lasting research capacity, develop centres of excellence, and improve institutional structures for ophthalmology research and innovation.
Due date: 01 October 2026, 23:59 CEST
For more information click: https://veluxstiftung.ch/funding-areas/ophthalmology/
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
The purpose of this engineering-oriented notice of funding opportunity (NOFO) announcement is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. This NOFO will support clinical trials that test functionality or validate performance in the chosen setting. Applications that propose phase III clinical trials are not sought by and will not be supported through this NOFO.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html
New Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-233.html
New Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant.
Due date: October 16, 2026
For more information click; https://grants.nih.gov/grants/guide/pa-files/PAR-25-143.html
New The Biocodex Microbiota Foundation Gut Microbiota International Call for Projects
The Biocodex Microbiota Foundation funds research projects focused on human gut microbiota related to health and disease. Every year, the call for proposals covers a specific theme chosen by an International Scientific Committee. Either clinical or fundamental research proposals can be submitted. The maximal duration of the project will be 3 years. The project should involve Microbiome analysis, Immunophenotyping and a dietary component. The project should be primarily performed in humans and in a disease context (Studies purely on healthy subjects are excluded). Pure observational studies should be avoided and some experimental validation is expected.
Due date: 30 November, 2026
For more information click; https://www.biocodexmicrobiotafoundation.com/international-research-grant/international-call-projects
New Emerging Global Leader Award (K43 Independent Clinical Trial Required)
The goal of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to a low- or middle-income country (LMIC) early career research scientist who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries, with exceptions below (see Section III. Eligibility Information)). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Notice of Funding Opportunity (NOFO) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.
Due date: 3 December 2026
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-295.html
New Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
The goal of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to a low- or middle-income country (LMIC) early career research scientist who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries, with exceptions below (see Section III. Eligibility Information)). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Notice of Funding Opportunity (NOFO)invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.
Due date: 3 December 2026
For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-296.html